CurrentUnitedHealthcarePolicy 2026T0638H

Interspinous Fusion and Decompression Devices

UnitedHealthcare Commercial and Individual Exchange medical policy defining medical necessity criteria for interspinous fixation (fusion) devices and coverage stance for interspinous decompression/interlaminar stabilization devices for lumbar spine (L1-S1). Includes applicable CPT codes, definitions, evidence summary, and NASS guidance references.

Policy Summary

PayerUnitedHealthcare

PolicyInterspinous Fusion and Decompression Devices

Policy CodePolicy 2026T0638H

Change TypeTemplate Update (no clinical changes)

Effective DateJan 1, 2026

Next Review Date

Key ActionDocument history, radiographic studies confirming disc degeneration, spondylolisthesis grade, prior nonoperative treatment duration (6 months) and specific imaging findings (25-50% foraminal diameter reduction) to support coverage determinations.

SourceLink

POLICY UPDATE CHANGES

Template Update creating shared policy version to support application to Oxford plan membership and archived previous policy version 2025T0638G and SURGERY 128.5.

1Medically necessary indication (interspinous fixation with fusion)

1Not medically necessary category (interspinous decompression without fusion)

8Applicable CPT codes listed

Coverage Summary

This UnitedHealthcare Commercial and Individual Exchange medical policy (Policy No. 2026T0638H) addresses interspinous fusion (fixation) and decompression/interlaminar stabilization (spacer) devices for the lumbar spine (L1–S1). The policy stance is mixed: interspinous fixation devices used to achieve fusion are considered medically necessary when performed per FDA labeling and specified clinical criteria, while interspinous decompression and interlaminar stabilization devices used without fusion are considered not medically necessary due to insufficient evidence. The policy effective date is January 1, 2026, with a non-material template update noted on 01/01/2026.

Key clinical thresholds

Nonoperative treatment duration6 months

Degenerative scoliosis limit<= 25°

Spondylolisthesis limitGrade I or less

Imaging stenosis severity25-50% reduction in lateral/central foraminal diameter vs adjacent levels

Sitting toleranceAt least 50 minutes without pain

Walking abilityCan walk at least 50 feet

BMI exclusion threshold>= 40

Medical-Necessity Criteria

Interspinous fixation (fusion) devices - Medically Necessary

Covered when ALL of the following are met:

ALL of the following

Performed according to FDA labeled indications, contraindications, warnings, and precautions
Back pain of discogenic origin, with degeneration of the disc confirmed by history and radiographic studies
No more than grade 1 spondylolisthesis
Used with an interbody cage as an adjunct to fusion at a single level in the lumbar spine (L1-S1)

NASS 2025 recommendations - Interspinous fixation with fusion (indications and exclusions summarized)

NASS supports use only when used as adjunct to fusion with qualifying conditions and lists exclusions:

Considered when

Utilized in context of lumbar fusion for diagnoses including stenosis, disc herniations, or synovial facet cysts
Adjunct to cyst excision involving removal of >50% of the facet joint
When utilized with robust open laminar and/or facet decortication and fusion, and/or robust autograft inter- and extra-spinous process decortication and fusion, and/or an interbody fusion of the same motion segment

Not indicated (examples)

Spondylolisthesis greater than Grade I
Bilateral isthmic spondylolysis

NASS 2025 recommendations - Interspinous distraction devices without fusion (static devices) - Indications and qualifying criteria

Static interspinous distraction devices without direct decompression may be indicated when ALL qualifying criteria are met:

ALL of the following

Clinically symptomatic degenerative lumbar stenosis associated with neurogenic claudication that is relieved by lumbar flexion
Sitting for at least 50 minutes without pain
Can walk at least 50 feet
Mild to moderate stenosis on CT or MRI defined as 25-50% reduction in lateral/central foraminal diameter compared to adjacent levels
Failure of 6 months nonoperative treatment

Interspinous decompression and interlaminar stabilization systems (without fusion) - Not Medically Necessary

Not covered due to insufficient evidence of efficacy:

Use of interspinous decompression and interlaminar stabilization systems without fusion for the treatment of spine pain or spinal stenosis

Provider Actions

Prior Authorization

Prior authorization implied for coverage review

Medical records documentation may be requested as part of a coverage review; benefit coverage is determined by the member-specific plan document and may vary by plan.

Refer to the member's plan document to confirm benefit coverage.

Documentation Required

Documentation to support medical necessity

Document the clinical history and imaging findings to support medical necessity, including prior nonoperative treatment duration and specific imaging severity.

History and radiographic studies confirming disc degeneration
Spondylolisthesis grade (no more than Grade I for fusion candidacy)
Prior nonoperative treatment duration: 6 months
Imaging demonstrating mild–moderate stenosis: 25–50% reduction in lateral/central foraminal diameter compared to adjacent levels

Billing Rule

Use applicable CPT codes

Report the procedure using the applicable CPT codes listed; inclusion of codes in the policy does not guarantee coverage or reimbursement.

22853
22854
22859
22867
22868
22869
22870
22899
Listing of codes does not guarantee coverage or reimbursement

Coding

Applicable CPT / Procedure Codes (reference only)CPT

22853	Insertion of interbody biomechanical device(s) ... in conjunction with interbody arthrodesis, each interspace
22854	Insertion of intervertebral biomechanical device(s) ... to vertebral corpectomy(ies) ... in conjunction with interbody arthrodesis
22859	Insertion of intervertebral biomechanical device(s) ... without interbody arthrodesis, each contiguous defect
22867	Insertion of interlaminar/interspinous process stabilization/distraction device, without fusion, with open decompression, lumbar; single level
22868	Insertion of interlaminar/interspinous process stabilization/distraction device, without fusion, with open decompression, lumbar; second level
22869	Insertion of interlaminar/interspinous process stabilization/distraction device, without open decompression or fusion, lumbar; single level
22870	Insertion of interlaminar/interspinous process stabilization/distraction device, without open decompression or fusion, lumbar; second level
22899	Unlisted procedure, spine [when specified as insertion of a non-pedicle interspinous process fixation device]

Background and Evidence Summary

Interspinous devices include two general types: interspinous fixation (fusion) devices that affix to the spinous processes to stabilize and promote arthrodesis (used as adjuncts to interbody fusion at a single level), and interspinous decompression / interlaminar stabilization (spacer) devices intended to provide indirect decompression by distracting spinous processes. The policy notes that evidence for decompression devices used without fusion is limited and of low qualityNASS 2025 guidance updating indications and exclusions for both fixation-with-fusion and static distraction devices, including specific qualifying criteria and scenarios where use is not indicated.

Evidence summaries: Systematic reviews and meta-analyses (Ge 2025, Han 2024, Pennington 2024, Poetscher 2018, Zhu & Xiao 2024) report mixed findings overall with low-to-moderate quality evidence and call for larger RCTs and longer-term data. Randomized controlled trials and comparative prospective studies (for example Baranidharan 2024, Schmidt 2018, Nunley 2017) show some clinically relevant improvements but are limited by small sample sizes, risk of bias, and inconsistent long-term outcomes. Health technology assessments (ECRI, Hayes) conclude the available studies are of low quality or at high risk of bias and indicate uncertainty about long-term patient-centered outcomes for devices such as Superion, Coflex, and Minuteman, supporting the need for further high-quality research.

Definitions

Policy metadata